Lithium and GSK-3: One inhibitor, two inhibitory actions, multiple outcomes

Research output: Contribution to journalShort surveypeer-review

383 Scopus citations

Abstract

The intrigue of lithium, the simplest drug in the modern pharmacopoeia, extends from its complex actions in cells to its therapeutic effects as a mood stabilizer. New surprises from studies of glycogen synthase kinase 3 (GSK-3) show that lithium reduces GSK-3 activity in two ways, both directly and by increasing the inhibitory phosphorylation of GSK-3. These dual effects can act in concert to magnify the influence of lithium on crucial GSK-3-regulated functions (gene expression, cell structure and survival).

Original languageEnglish (US)
Pages (from-to)441-443
Number of pages3
JournalTrends in Pharmacological Sciences
Volume24
Issue number9
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint Dive into the research topics of 'Lithium and GSK-3: One inhibitor, two inhibitory actions, multiple outcomes'. Together they form a unique fingerprint.

Cite this